Literature DB >> 27626956

Asnovolins A-G, Spiromeroterpenoids Isolated from the Fungus Aspergillus novofumigatus, and Suppression of Fibronectin Expression by Asnovolin E.

Kazuki Ishikawa1, Fumiaki Sato1, Takeshi Itabashi1, Hiroshi Wachi1, Hisashi Takeda1, Daigo Wakana1, Takashi Yaguchi2, Ken-Ichi Kawai1, Tomoo Hosoe1.   

Abstract

Seven novel spiromeroterpenoids, asnovolins A-G (1-7), one of which was shown to suppress fibronectin expression, were isolated from Aspergillus novofumigatus CBS117520 along with a known compound, novofumigatonin (8). The structures of asnovolins A-G were elucidated using MS and 2D-NMR data. Asnovolin E (5) suppressed fibronectin expression by normal human neonatal dermal fibroblast cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27626956     DOI: 10.1021/acs.jnatprod.6b00013

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Chermebilaenes A and B, New Bioactive Meroterpenoids from Co-Cultures of Marine-Derived Isolates of Penicillium bilaiae MA-267 and Penicillium chermesinum EN-480.

Authors:  Ling-Hong Meng; Xiao-Ming Li; Hong-Lei Li; Bin-Gui Wang
Journal:  Mar Drugs       Date:  2020-06-28       Impact factor: 5.118

2.  Bioactive terpenoids from Santalum album derived endophytic fungus Fusarium sp. YD-2.

Authors:  Chong Yan; Weiyang Liu; Jing Li; Yanlian Deng; Senhua Chen; Hongju Liu
Journal:  RSC Adv       Date:  2018-04-19       Impact factor: 3.361

3.  Production of secondary metabolites in stirred tank bioreactor co-cultures of Streptomyces noursei and Aspergillus terreus.

Authors:  Tomasz Boruta; Anna Ścigaczewska; Marcin Bizukojć
Journal:  Front Bioeng Biotechnol       Date:  2022-09-29

4.  Novofumigatonin biosynthesis involves a non-heme iron-dependent endoperoxide isomerase for orthoester formation.

Authors:  Yudai Matsuda; Tongxuan Bai; Christopher B W Phippen; Christina S Nødvig; Inge Kjærbølling; Tammi C Vesth; Mikael R Andersen; Uffe H Mortensen; Charlotte H Gotfredsen; Ikuro Abe; Thomas O Larsen
Journal:  Nat Commun       Date:  2018-07-03       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.